omeprazole has been researched along with rifampin in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (7.02) | 18.2507 |
2000's | 18 (31.58) | 29.6817 |
2010's | 26 (45.61) | 24.3611 |
2020's | 9 (15.79) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Amore, BM; Banfield, C; Boudreaux, MD; Davis, JA; Emery, MG; Foti, RS; Pearson, JT; Prokop, SP; Rock, DA; Wahlstrom, JL; Wienkers, LC; Wong, SL; Zalikowski, JA | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Baell, JB; Board, PG; Casarotto, MG; Dahlin, JL; Oakley, AJ; Xie, Y | 1 |
Chen, J; Ding, C; Doyle, T; Duncan, L; Ebright, RH; He, S; Lin, W; Liu, Y; Lynch, AS; Ma, Z; Molodtsov, V; Nguyen, P; Pulse, M; Robertson, GT; Wang, H; Weiss, WJ; Xu, X; Yuan, Y; Zhuang, Z | 1 |
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
Bories, P; Daujat, M; Diaz, D; Fabre, I; Maurel, P; Michel, H; Saint Aubert, B | 1 |
Hirata, M; Nishibe, Y | 2 |
Li, AP; Masubuchi, N; Okazaki, O | 1 |
Li, AP; Lu, C | 1 |
Hiraoka, I; Naito, S; Nishimura, M; Yoshitsugu, H | 1 |
Allen, SW; Raucy, J; Warfe, L; Yueh, MF | 1 |
Booker, BM; Brazeau, D; Cloen, D; Frerichs, V; Frye, RF; Haas, CE; Kufel, T; Zaranek, C | 1 |
Marks, B; Raucy, J; Trubetskoy, O; Yueh, MF; Zielinski, T | 1 |
Kawano, Y; Koeda, A; Naito, S; Nakayama, M; Narimatsu, S; Nishimura, M; Satoh, T; Shimizu, T; Suzuki, E | 1 |
Kawano, Y; Koeda, A; Naito, S; Nakayama, M; Narimatsu, S; Nishimura, M; Satoh, T; Suzuki, E | 1 |
Bumb, RA; Kochar, DK; Kochar, SK; Mehta, RD; Purohit, SK; Saini, G; Sirohi, P | 1 |
Koeda, A; Naito, S; Nakayama, M; Narimatsu, S; Nishimura, M; Satoh, T; Shimizu, T; Suganuma, Y; Suzuki, E | 1 |
Dial, S; Guo, L; Ning, B; Sun, Y; Wang, J; Yang, J | 1 |
Andersson, TB; Bäckström, T; Bertilsson, L; Böttiger, Y; Bredberg, E; Diczfalusy, U; Kanebratt, KP; Sparve, E | 1 |
de Barros e Silva, MJ; de Paiva, TF; Fanelli, MF; Gimenes, DL; Rinck, JA | 1 |
Koeda, A; Morikawa, H; Naito, S; Narimatsu, S; Nishimura, M; Satoh, T | 1 |
Abadie-Viollon, C; Alexandre, E; Bachellier, P; Blanchard, N; Coassolo, P; Heyd, B; Mantion, G; Martin, H; Pekthong, D; Richert, L; Schuler, F | 1 |
Burger, DM | 1 |
Anthérieu, S; Camus, S; Chesné, C; Guguen-Guillouzo, C; Guillouzo, A; Lahoz, A; Li, R; Picazo, L; Tolonen, A; Turpeinen, M; Uusitalo, J | 1 |
Akiyama, H; Ise, R; Iwasaki, K; Kondo, S; Nagata, R; Nobumasa, H; Uehara, S; Uno, Y; Yamazaki, H | 1 |
Jiang, K; Li, F; Li, K; Lu, X; Qin, F | 1 |
Aizawa, K; Kato, N; Mizutani, R; Nakamura, K; Tanoue, A; Yamauchi, J | 1 |
Akamatsu, T; Chida, K; Inui, N; Karayama, M; Namiki, N; Tanaka, S; Uchida, S; Watanabe, H | 1 |
Buchbjerg, JK; Chen, G; Højer, AM; Lee, R; Serenko, M; Zhao, Z | 1 |
Bradfield, CA; Johnson, BP; Sengupta, S; Stewart, R; Swanson, SA; Thomson, JA | 1 |
Hori, Y; Ohara, Y; Takahashi, Y; Tanaka, H; Urashima, T; Yamamoto, T | 1 |
Inoue, T; Sasaki, E; Suzuki, T; Uehara, S; Uno, Y; Utoh, M; Yamazaki, H | 1 |
Damanhuri, NS; Kumolosasi, E; Omar, MS | 1 |
Bae, SH; Han, S; Park, GJ; Park, MH; Park, WS; Shin, SH; Shin, YG; Yim, DS | 1 |
Inoue, T; Kusama, T; Mogi, M; Sasaki, E; Shimizu, M; Toda, A; Uehara, S; Uno, Y; Utoh, M; Yamazaki, H | 1 |
Arakawa, H; Itoh, M; Kojima, H; Koyama, S; Masuda, N; Ogihara, T; Yano, K | 1 |
Hakamata, A; Inui, N; Kamiya, C; Miyakawa, S; Namiki, N; Odagiri, K; Tanaka, S; Uchida, S; Watanabe, H | 1 |
Crampton, AL; Khetani, SR; Kukla, DA; Wood, DK | 1 |
Iwao, T; Koeda, A; Matsunaga, T; Mizuno, S; Nakamura, K; Nakanishi, A; Sakai, Y; Yamashita, M | 1 |
Damanhuri, NS; Kumolosasi, E; Mansor, AH; Omar, MS; Razak, AFA | 1 |
Alabanza, A; Lohmer, L; Patel, J; Schueller, O; Singh, N; Willson, A | 1 |
Blank, A; Burhenne, J; Elbe, A; Foerster, KI; Haefeli, WE; Mikus, G; Rose, P | 1 |
Aarnoutse, RE; Boeree, MJ; Coenen, MJH; Colbers, A; Dawson, R; Diacon, AH; Fuhr, U; Jager, Vd; Narunsky, K; Padayachee, SD; Phillips, PPJ; Stemkens, R; Svensson, EM; Te Brake, LHM; van Beek, SW | 1 |
Murayama, N; Suemizu, H; Uehara, S; Uno, Y; Ushirozako, G; Yamazaki, H | 1 |
4 review(s) available for omeprazole and rifampin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example.
Topics: Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fluorescence Polarization; Glutathione Transferase; Humans | 2018 |
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
Drug-drug interactions with raltegravir.
Topics: Antibiotics, Antitubercular; Antiviral Agents; Drug Interactions; Enzyme Inhibitors; HIV Infections; HIV Integrase Inhibitors; Humans; Omeprazole; Pyrrolidinones; Raltegravir Potassium; Rifampin | 2009 |
6 trial(s) available for omeprazole and rifampin
Article | Year |
---|---|
Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction.
Topics: Adult; Caffeine; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Gene Expression Regulation, Enzymologic; Humans; Leukocytes, Mononuclear; Male; Midazolam; Omeprazole; Rifampin; RNA, Messenger | 2005 |
A double blind, randomised placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis.
Topics: Adolescent; Adult; Aged; Animals; Antiprotozoal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Middle Aged; Omeprazole; Rifampin; Treatment Outcome | 2006 |
Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol.
Topics: Adult; Anti-Ulcer Agents; Antibiotics, Antitubercular; Antihypertensive Agents; Antimalarials; Caffeine; Central Nervous System Stimulants; Cytochrome P-450 Enzyme System; Drug Combinations; Enzyme Induction; Female; Humans; Hydroxycholesterols; Losartan; Male; Middle Aged; Omeprazole; Quinine; Rifampin | 2008 |
Pharmacokinetic drug interactions involving vortioxetine (Lu AA21004), a multimodal antidepressant.
Topics: Adolescent; Adult; Antidepressive Agents; Antifungal Agents; Bupropion; Cohort Studies; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Female; Fluconazole; Humans; Ketoconazole; Male; Middle Aged; Omeprazole; Piperazines; Rifampin; Single-Blind Method; Sulfides; Vortioxetine; Young Adult | 2013 |
Drug-drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer.
Topics: Adult; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Healthy Volunteers; Humans; Male; Middle Aged; Omeprazole; Rifampin; Young Adult | 2017 |
A Phase 1 Pharmacokinetic Drug Interaction Study of Belumosudil Coadministered With CYP3A4 Inhibitors and Inducers and Proton Pump Inhibitors.
Topics: Acetamides; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Humans; Itraconazole; Omeprazole; Protein Kinases; Proton Pump Inhibitors; Rabeprazole; Rifampin | 2022 |
47 other study(ies) available for omeprazole and rifampin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Predicting the drug interaction potential of AMG 853, a dual antagonist of the D-prostanoid and chemoattractant receptor-homologous molecule expressed on T helper 2 cells receptors.
Topics: Adolescent; Adult; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Glucuronosyltransferase; Hepatocytes; Humans; Ketoconazole; Kinetics; Lung; Male; Microsomes, Liver; Middle Aged; Phenylacetates; Prostaglandins; Receptors, Immunologic; Receptors, Prostaglandin; Sulfonamides; Young Adult | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Topics: Anaerobiosis; DNA-Directed RNA Polymerases; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Rifamycins | 2022 |
Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.
Topics: Aged; Benzoflavones; beta-Naphthoflavone; Blotting, Northern; Blotting, Western; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Half-Life; Humans; In Vitro Techniques; Liver; Male; Methylcholanthrene; Middle Aged; Omeprazole; Oxygenases; Rifampin; RNA, Messenger | 1990 |
Effect of phenobarbital and other model inducers on cytochrome P450 isoenzymes in primary culture of dog hepatocytes.
Topics: 7-Alkoxycoumarin O-Dealkylase; Animals; Benzoflavones; beta-Naphthoflavone; Blotting, Western; Cells, Cultured; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Dogs; Enzyme Induction; Isoenzymes; Kinetics; Liver; Male; Microsomes, Liver; Omeprazole; Oxidoreductases; Phenobarbital; Rifampin; Steroid 16-alpha-Hydroxylase | 1993 |
Induction of cytochrome P450 3A (CYP 3A) by E 5110, a non-steroidal anti-inflammatory agent (NSAID), and typical CYP 3A inducers in primary cultures of dog hepatocytes.
Topics: 7-Alkoxycoumarin O-Dealkylase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbamazepine; Cells, Cultured; Clofibrate; Clotrimazole; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dogs; Drug Interactions; Enzyme Induction; Liver; Male; Mixed Function Oxygenases; Omeprazole; Phenobarbital; Phenytoin; Pyrrolidinones; Rifampin; Steroid Hydroxylases | 1995 |
An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzimidazoles; Blotting, Western; Cells, Cultured; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Humans; Lansoprazole; Liver; Male; Methylcholanthrene; Middle Aged; Omeprazole; Pantoprazole; Rifampin; Steroid Hydroxylases; Structure-Activity Relationship; Sulfoxides | 1998 |
Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog.
Topics: Adult; Aged; Animals; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Dexamethasone; Dogs; Enzyme Induction; Female; Hepatocytes; Humans; Male; Middle Aged; Omeprazole; Rats; Rats, Sprague-Dawley; Rifampin; Species Specificity; Swine, Miniature | 2001 |
Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR.
Topics: Aged; Alcohol Dehydrogenase; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cells, Cultured; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Hepatocytes; Humans; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger; Sensitivity and Specificity | 2002 |
A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system.
Topics: Base Sequence; Blotting, Northern; Cell Line, Transformed; Cell Survival; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA Primers; Enzyme Induction; Genes, Reporter; Hepatocytes; Humans; Liver; Lovastatin; Luciferases; Mifepristone; Mixed Function Oxygenases; Omeprazole; Polychlorinated Dibenzodioxins; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger; Transcription, Genetic; Transfection | 2002 |
A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Chromans; Clotrimazole; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Dimethyl Sulfoxide; Enhancer Elements, Genetic; Enzyme Induction; Genes, Reporter; Genes, Synthetic; Humans; Ketoconazole; Liver Neoplasms; Lovastatin; Luciferases; Mifepristone; Neoplasm Proteins; Nifedipine; Omeprazole; Paclitaxel; Phenytoin; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Recombinant Fusion Proteins; Rifampin; Thiazolidinediones; Transcription, Genetic; Troglitazone; Troleandomycin | 2005 |
Effects of prototypical drug-metabolizing enzyme inducers on mRNA expression of housekeeping genes in primary cultures of human and rat hepatocytes.
Topics: Adult; Aged; Animals; Cells, Cultured; Child, Preschool; Dexamethasone; Female; Gene Expression Regulation; Genes; Hepatocytes; Humans; Inactivation, Metabolic; Omeprazole; Pharmaceutical Preparations; Rats; Rats, Sprague-Dawley; Rifampin; RNA, Messenger | 2006 |
Regulation of mRNA expression of MDR1, MRP1, MRP2 and MRP3 by prototypical microsomal enzyme inducers in primary cultures of human and rat hepatocytes.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Dexamethasone; Enzyme Induction; Enzyme Inhibitors; Female; Gene Expression Regulation; Hepatocytes; Humans; Membrane Transport Proteins; Microsomes; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Omeprazole; Rats; Rats, Sprague-Dawley; Rifampin; RNA, Messenger; Transcription, Genetic | 2006 |
Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes.
Topics: Adult; Aged; Animals; Aryl Hydrocarbon Hydroxylases; Cells, Cultured; Child, Preschool; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Female; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Macaca fascicularis; Male; Omeprazole; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger | 2007 |
Systematic and simultaneous gene profiling of 84 drug-metabolizing genes in primary human hepatocytes.
Topics: Brain; Cells, Cultured; Gene Expression Profiling; Gene Expression Regulation; Hepatocytes; Humans; Inactivation, Metabolic; Methylcholanthrene; Omeprazole; Polymerase Chain Reaction; Principal Component Analysis; Rifampin; RNA | 2008 |
Tuberculosis in a patient on temozolomide: a case report.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antibiotics, Antitubercular; Anticholesteremic Agents; Anticonvulsants; Antineoplastic Agents, Alkylating; Atorvastatin; Brain Neoplasms; Combined Modality Therapy; Cyclosporine; Dacarbazine; Dexamethasone; Female; Fluoxetine; Glioblastoma; Heptanoic Acids; Humans; Immunosuppressive Agents; Isoniazid; Middle Aged; Omeprazole; Phenobarbital; Prednisone; Pyrazinamide; Pyrroles; Radiotherapy; Red-Cell Aplasia, Pure; Rifampin; Temozolomide; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary | 2009 |
Comparison of inducibility of multidrug resistance (MDR)1, multidrug resistance-associated protein (MRP)1, and MRP2 mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cryopreservation; Dexamethasone; Enzyme Induction; Female; Hepatocytes; Humans; Macaca fascicularis; Microsomes, Liver; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger; Species Specificity | 2008 |
Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
Topics: Adult; Aged; Antibiotics, Antitubercular; beta-Naphthoflavone; Cell Culture Techniques; Cell Separation; Cryopreservation; Cytochrome P-450 Enzyme System; Enzyme Induction; Enzyme Inhibitors; Female; Follow-Up Studies; Hepatocytes; Humans; Indicators and Reagents; Isoenzymes; Male; Middle Aged; Omeprazole; Phenobarbital; Proton Pump Inhibitors; Reference Standards; Rifampin; RNA, Messenger; Young Adult | 2010 |
Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
Topics: Cell Culture Techniques; Cell Differentiation; Cell Line, Transformed; Cells, Cultured; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Enzyme Induction; Gene Expression Regulation; Glucuronosyltransferase; Glutathione Transferase; Hepatocytes; Humans; Isoenzymes; Membrane Transport Proteins; Omeprazole; Phenobarbital; Receptors, Cytoplasmic and Nuclear; Reproducibility of Results; Rifampin; RNA, Messenger; Time Factors; Xenobiotics | 2010 |
A newly developed DNA microarray is useful to assess induction of cytochromes p450 in the cynomolgus monkey.
Topics: Animal Structures; Animals; Cells, Cultured; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Enzyme Induction; Gene Expression; Hepatocytes; Ileum; Isoenzymes; Jejunum; Kidney Cortex; Kidney Medulla; Liver; Macaca fascicularis; Male; Oligonucleotide Array Sequence Analysis; Omeprazole; Rifampin | 2011 |
Assessment of a novel β2-adrenoceptor agonist, trantinterol, for interference with human liver cytochrome P450 enzymes activities.
Topics: Adrenergic Agonists; Aryl Hydrocarbon Hydroxylases; Cells, Cultured; Clenbuterol; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Hepatocytes; Humans; Mass Spectrometry; Microsomes, Liver; Nonlinear Dynamics; Omeprazole; Rifampin | 2011 |
Expression of albumin and cytochrome P450 enzymes in HepG2 cells cultured with a nanotechnology-based culture plate with microfabricated scaffold.
Topics: Albumins; CCAAT-Enhancer-Binding Protein-alpha; Cell Culture Techniques; Cell Survival; Cytochrome P-450 Enzyme System; Enzyme-Linked Immunosorbent Assay; Hep G2 Cells; Hepatocyte Nuclear Factor 4; Humans; Microtechnology; Nanotechnology; Omeprazole; Real-Time Polymerase Chain Reaction; Rifampin | 2011 |
Chronological effects of rifampicin discontinuation on cytochrome P450 activity in healthy Japanese volunteers, using the cocktail method.
Topics: Adult; Antibiotics, Antitubercular; Asian People; Caffeine; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Imidazoles; Losartan; Male; Midazolam; Omeprazole; Rifampin; Tetrazoles; Theophylline; Time Factors; Withholding Treatment | 2013 |
Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing.
Topics: Acetaminophen; Cell Aggregation; Cell Culture Techniques; Cell Differentiation; Chromatography, Liquid; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Drug Discovery; Embryonic Stem Cells; Enzyme Induction; Hep G2 Cells; Hepatocytes; Humans; Omeprazole; Pluripotent Stem Cells; Rifampin; Tandem Mass Spectrometry; Toxicity Tests | 2014 |
3D spheroid cultures improve the metabolic gene expression profiles of HepaRG cells.
Topics: Albumins; Apolipoproteins B; Cell Culture Techniques; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme System; Glucose; Hep G2 Cells; High-Throughput Screening Assays; Humans; Lipid Metabolism; Lipoproteins, LDL; Liver; Omeprazole; Phenobarbital; Rifampin; Spheroids, Cellular; Transcriptome | 2015 |
Strong Induction of Cytochrome P450 1A/3A, But not P450 2B, in Cultured Hepatocytes from Common Marmosets and Cynomolgus Monkeys by Typical Human P450 Inducing Agents.
Topics: Animals; Callithrix; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inducers; Drug Evaluation, Preclinical; Drug Interactions; Feasibility Studies; Hepatocytes; Humans; Macaca fascicularis; Male; Models, Animal; Omeprazole; Phenobarbital; Reverse Transcriptase Polymerase Chain Reaction; Rifampin | 2017 |
Influences of proton pump inhibitor on Helicobacter pylori adherence to the gastrointestinal cell lines.
Topics: Antibiotics, Antitubercular; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bacterial Adhesion; Caco-2 Cells; Esomeprazole; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Rifampin; Time Factors | 2017 |
Effects of aging and rifampicin pretreatment on the pharmacokinetics of human cytochrome P450 probes caffeine, warfarin, omeprazole, metoprolol and midazolam in common marmosets genotyped for cytochrome P450 2C19.
Topics: Administration, Intravenous; Aging; Animals; Caffeine; Callithrix; Cytochrome P-450 CYP2C19; Genotype; Humans; Male; Metoprolol; Midazolam; Omeprazole; Rifampin; Substrate Specificity; Warfarin | 2018 |
Evaluation of the metabolic capability of primary human hepatocytes in three-dimensional cultures on microstructural plates.
Topics: Acetaminophen; Adenosine Triphosphate; Arylsulfotransferase; Cell Culture Techniques; Cells, Cultured; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme System; Diclofenac; Glucuronosyltransferase; Hepatocytes; Humans; Lamotrigine; Midazolam; Omeprazole; Rifampin; RNA, Messenger; Triazines | 2018 |
Effect of co-administered inducer or inhibitor on omeprazole pharmacokinetics based on CYP2C19 genotype.
Topics: Adult; Alleles; Cytochrome P-450 CYP2C19; Drug Interactions; Fluvoxamine; Genetic Association Studies; Genotype; Humans; Male; Omeprazole; Proton Pump Inhibitors; Rifampin; Young Adult | 2019 |
Microscale Collagen and Fibroblast Interactions Enhance Primary Human Hepatocyte Functions in Three-Dimensional Models.
Topics: 3T3 Cells; Animals; Cell Encapsulation; Cells, Cultured; Coculture Techniques; Collagen Type I; Cytochrome P-450 Enzyme System; Enzyme Induction; Gels; Gene Expression; Hepatic Stellate Cells; Hepatocytes; Humans; Lab-On-A-Chip Devices; Mice; Omeprazole; Polymerization; Rifampin; Spheroids, Cellular; Tissue Engineering | 2020 |
Comparison of the inducibility of CYP mRNA exposed to typical inducers in fresh and cryopreserved cynomolgus monkey hepatocytes.
Topics: Animals; Cell Survival; Cells, Cultured; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; Hepatocytes; Liver; Macaca fascicularis; Male; Omeprazole; Phenobarbital; Rifampin; RNA, Messenger | 2020 |
The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley rats.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cyclosporine; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Proton Pump Inhibitors; Rats, Sprague-Dawley; Rifampin; Stomach Ulcer | 2021 |
Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans.
Topics: Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Fluconazole; Humans; Midazolam; Omeprazole; Rifampin; Sodium Bicarbonate; Yohimbine | 2022 |
Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis.
Topics: Adult; Caffeine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dextromethorphan; Digoxin; Drug Interactions; Humans; Midazolam; Omeprazole; Rifampin; Tolbutamide; Tuberculosis, Pulmonary | 2023 |
Cytochrome P450 1A2 and 2C enzymes autoinduced by omeprazole in dog hepatocytes and human HepaRG and HepaSH cells are involved in omeprazole 5-hydroxylation and sulfoxidation.
Topics: Animals; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Dogs; Hepatocytes; Humans; Hydroxylation; Microsomes, Liver; Omeprazole; Rifampin | 2023 |